AIM
TMO icon

Axiom Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Axiom Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Buy
+691
New +$375K 0.26% 70
2022
Q4 		$312K Buy
567
+59
+12% +$31.3K 0.81% 40
2022
Q3 		$259K Sell
508
-13
-2% -$7.28K 0.52% 44
2022
Q2 		$282K Sell
521
-3
-0.6% -$1.65K 0.81% 46
2022
Q1 		$310K Sell
524
-169
-24% -$97.1K 0.67% 49
2021
Q4 		$462K Sell
693
-40
-5% -$25K 0.45% 59
2021
Q3 		$420K Hold
733
– – 0.42% 59
2021
Q2 		$374K Buy
733
+49
+7% +$23.1K 0.29% 81
2021
Q1 		$312K Sell
684
-9,568
-93% -$4.57M 0.25% 98
2020
Q4 		$319 Buy
10,252
+9,491
+1,247% +$4.45M 0.29% 84
2020
Q3 		$336K Sell
761
-57
-7% -$23.5K 0.38% 64
2020
Q2 		$297K Buy
818
+89
+12% +$29.8K 0.39% 72
2020
Q1 		$208K Sell
729
-34
-4% -$10.7K 0.37% 79
2019
Q4 		$247K Sell
763
-1,036
-58% -$314K 0.35% 87
2019
Q3 		$523K Sell
1,799
-7,823
-81% -$2.24M 0.4% 73
2019
Q2 		$2.83M Sell
9,622
-129
-1% -$35.5K 0.51% 47
2019
Q1 		$2.66M Buy
9,751
+53
+0.5% +$13.2K 0.51% 47
2018
Q4 		$2.17M Buy
+9,698
New +$2.28M 0.46% 55

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Axiom Investment Management's TMO Position: Q1 2026 in Review

Axiom Investment Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 691 shares worth $340K. The stake represents 0.26% of the portfolio and ranks #70 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in TMO as recently as Q4 2022.

Axiom Investment Management first reported a position in TMO in Q4 2018 and has held it in 18 quarters since. The position peaked at $2.83M in Q2 2019. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Axiom Investment Management held 691 shares of Thermo Fisher Scientific worth $340K as of Q1 2026.
  • Thermo Fisher Scientific was a new Axiom Investment Management position in Q1 2026.
  • Thermo Fisher Scientific made up 0.26% of Axiom Investment Management's portfolio in Q1 2026, its #70 holding.
  • Axiom Investment Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 18 quarters since.
  • Axiom Investment Management's Thermo Fisher Scientific position peaked at $2.83M in Q2 2019.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.